Skip to main content
SpringerLink
Log in

A Psychodynamic Approach to Treatment Resistance

  • Chapter
  • First Online:
Treatment Resistance in Psychiatry

Abstract

Despite the growth of neurobiologic research in psychiatry, the fundamental clinical problems of psychiatry remain unresolved. “Treatment resistance” has become an increasingly recognized problem. Meanwhile, financial and academic support for psychodynamic concepts has decreased, with a troubling bias against psychodynamic ideas. Nevertheless, psychodynamic concepts and psychodynamic therapy (PDT) offer opportunities for novel, effective approaches to treatment resistance. Conceptual errors in mainstream psychiatry include ignoring the meaning of psychiatric symptoms, assuming that patients are best described by single diagnoses, assuming that mental illness is always caused by a specific biological pathology that can be addressed by a biological treatment, neglecting the effects of the psychosocial context on treatment, and failing to attend to the treatment alliance. This chapter reviews literature describing psychodynamic approaches to treatment resistance and demonstrating the relevance of psychodynamic concepts and the effectiveness of psychodynamic therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mathew SJ. Review of treatment resistant depression: a roadmap for effective care. J Psychiatr Pract. 2012;18(5):388–9.

    Article  Google Scholar 

  2. Posse PR, Nemeroff CB. The problem of treatment-resistant psychiatric disorders. In: Nemeroff CB, editor. Management of treatment-resistant major psychiatric disorders. Oxford, New York: Oxford University Press; 2012. p. 3–21.

    Google Scholar 

  3. Plakun EM, editor. Treatment resistance and patient authority: the Austen Riggs reader. 1st ed. New York: W.W. Norton & Co; 2011. 305 p

    Google Scholar 

  4. Schuklenk U, van de Vathorst S. Treatment-resistant major depressive disorder and assisted dying. J Med Ethics. 2015;41(8):577–83.

    Article  PubMed  Google Scholar 

  5. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 2007;68:1062–70.

    Article  PubMed  Google Scholar 

  6. Kaplan M, Klinetob N. Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression. J Nerv Ment Dis. 2000;188(9):596–601.

    Article  CAS  PubMed  Google Scholar 

  7. Hassan AN, De Luca V. The effect of lifetime adversities on resistance to antipsychotic treatment in schizophrenia patients. Schizophr Res. 2015;161(2–3):496–500.

    Article  PubMed  Google Scholar 

  8. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry. 2002;159(3):469–73.

    Article  PubMed  Google Scholar 

  9. Balint E. A study of the doctor-patient relationship using randomly selected cases. J Coll Gen Pract. 1967;13(2):163–73.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Plakun EM. Finding psychodynamic psychiatry’s lost generation. J Am Acad Psychoanal Dyn Psychiatry. 2006;34(1):135–50.

    Article  PubMed  Google Scholar 

  11. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748–51.

    Article  PubMed  Google Scholar 

  12. Rogers A. Star neuroscientist Tom Insel leaves the Google-spawned verily for… a Startup? WIRED. 2017.

    Google Scholar 

  13. Steinert C, Munder T, Rabung S, Hoyer J, Leichsenring F. Psychodynamic therapy: as efficacious as other empirically supported treatments? A meta-analysis testing equivalence of outcomes. Am J Psychiatry. 2017;174(10):943–53.

    Article  PubMed  Google Scholar 

  14. Fonagy P, Rost F, Carlyle J-A, Mcpherson S, Thomas R, Pasco Fearon RM, et al. Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS). World Psychiatry. 2015;14:312–21.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Bardes CL. Defining “patient-centered medicine.”. N Engl J Med. 2012;366(9):782–3.

    Article  CAS  PubMed  Google Scholar 

  16. Balint E. The possibilities of patient-centered medicine. J R Coll Gen Pract. 1969;17(82):269–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press (US); 2001. [cited 2017 Oct 27]. Available from https://www.ncbi.nlm.nih.gov/books/NBK222271/.

    Google Scholar 

  18. Mead N, Bower P. Patient-centredness: a conceptual framework and review of the empirical literature. Soc Sci Med. 2000;51(7):1087–110.

    Article  CAS  PubMed  Google Scholar 

  19. Balint M. The doctor, his patient and the illness. London: Pitman Medical Publishing Co; 1964.

    Google Scholar 

  20. Stigma SM. Stigma. Adv Psychiatr Treat. 2002;8(5):317–25.

    Article  Google Scholar 

  21. Pescosolido BA, Martin JK, Long JS, Medina TR, Phelan JC, Link BG. “A disease like any other”? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry. 2010;167:1321–30.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Schnittker J. An uncertain revolution: why the rise of a genetic model of mental illness has not increased tolerance. Soc Sci Med. 2008;67(9):1370–81.

    Article  PubMed  Google Scholar 

  23. Blagys MD, Hilsenroth MJ. Distinctive feature of short-term psychodynamic-interpersonal psychotherapy: a review of the comparative psychotherapy process literature. Clin Psychol Sci Pract. 2000;7(2):167–88.

    Article  Google Scholar 

  24. Plakun EM. Treatment refractory mood disorders: a psychodynamic perspective. J Psychiatr Pract. 2003;9(3):209–18.

    Article  PubMed  Google Scholar 

  25. Mintz D, Belnap BA. View from Riggs: treatment resistance and patient authority—III. What is psychodynamic psychopharmacology? An approach to pharmacologic treatment resistance. J Am Acad Psychoanal Dyn Psychiatry. 2016;34(4):581–601.

    Article  Google Scholar 

  26. Kendler KS. Toward a philosophical structure for psychiatry. Am J Psychiatry. 2005;162(3):433–40.

    Article  PubMed  Google Scholar 

  27. Plakun EM. Psychotherapy and psychosocial treatment: recent advances and future directions. Psychiatr Clin North Am. 2015;38(3):405–18.

    Article  PubMed  Google Scholar 

  28. Mintz DL, Flynn DF. How (not what) to prescribe: nonpharmacologic aspects of psychopharmacology. Psychiatr Clin North Am. 2012;35(1):143–63.

    Article  PubMed  Google Scholar 

  29. Thase ME, Friedman ES, Howland RH. Management of treatment-resistant depression: psychotherapeutic perspectives. J Clin Psychiatry. 2001;62(SUPPL. 18):18–24.

    PubMed  Google Scholar 

  30. McKay KM, Imel ZE, Wampold BE. Psychiatrist effects in the psychopharmacological treatment of depression. J Affect Disord. 2006;92(2–3):287–90.

    Article  PubMed  Google Scholar 

  31. Wampold BE, Mondin GW, Moody M, Stich F, Benson K, Ahn H. A meta-analysis of outcome studies comparing bona fide psychotherapies: empirically, “all must have prizes.”. Psychol Bull. 1997;122(3):203–15.

    Article  Google Scholar 

  32. Plakun EM, Sudak DM, Goldberg D. The Y model: an integrated, evidence-based approach to teaching psychotherapy competencies. J Psychiatr Pract. 2009;15(1):5–11.

    Article  PubMed  Google Scholar 

  33. Fonagy P. The effectiveness of psychodynamic psychotherapy: an update. World Psychiatry. 2015;14:137–50.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Leichsenring F, Luyten P, Hilsenroth MJ, Abbass A, Barber JP, Keefe JR, et al. Psychodynamic therapy meets evidence-based medicine: a systematic review using updated criteria. Lancet Psychiatry. 2015;2(7):648–60.

    Article  PubMed  Google Scholar 

  35. Abbass AA, Kisely SR, Town JM, Leichsenring F, Driessen E, De Maat S, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014;7:CD004687.

    Google Scholar 

  36. National Collaborating Centre for Mental Health (UK). Depression: the treatment and management of depression in adults (Updated Edition) [Internet]. Leicester: British Psychological Society; 2010 [cited 2017 Dec 21]. (National Institute for Health and Clinical Excellence: Guidance). Available from: http://www.ncbi.nlm.nih.gov/books/NBK63748/.

  37. Shedler J. The efficacy of psychodynamic psychotherapy. Am Psychol. 2010;65(2):98–109.

    Article  PubMed  Google Scholar 

  38. Blatt SJ, Corveleyn J, Luyten P. Minding the gap between positivism and hermeneutics in psychoanalytic research. J Am Psychoanal Assoc. 2006;54(2):571–610.

    Article  PubMed  Google Scholar 

  39. Markowitz JC, Lipsitz J, Milrod BL. Critical review of outcome research on interpersonal psychotherapy for anxiety disorders. Depress Anxiety. 2014;31:316–25.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Abbass A, Luyten P, Steinert C, Leichsenring F. Bias toward psychodynamic therapy: framing the problem and working toward a solution. J Psychiatr Pract. 2017;23(5):361–5.

    Article  PubMed  Google Scholar 

  41. Leichsenring F, Rabung S, Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 2004;61(12):1208–16.

    Article  PubMed  Google Scholar 

  42. Leichsenring F, Rabung S. Effectiveness of long-term psychodynamic psychotherapy: a meta-analysis. JAMA. 2008;300(13):1551–65.

    Article  CAS  PubMed  Google Scholar 

  43. Kessler RC, McLaughlin KA, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM, et al. Childhood adversities and adult psychopathology in the WHO world mental health surveys. Br J Psychiatry. 2010;197(5):378–85.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Caspi A, Houts RM, Belsky DW, Goldman-Mellor SJ, Harrington H, Israel S, et al. The p factor: one general psychopathology factor in the structure of psychiatric disorders? Clin Psychol Sci. 2014;2(2):119–37.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Martel MM, Pan PM, Hoffmann MS, Gadelha A, do Rosário MC, Mari JJ, et al. A general psychopathology factor (P factor) in children: structural model analysis and external validation through familial risk and child global executive function. Abnorm Psychol. 2017;126(1):137–48.

    Article  Google Scholar 

  46. Lahey BB, Rathouz PJ, Keenan K, Stepp SD, Loeber R, Hipwell AE. Criterion validity of the general factor of psychopathology in a prospective study of girls. J Child Psychol Psychiatry. 2015;56(4):415–22.

    Article  PubMed  Google Scholar 

  47. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci. 2003;100(24):14293–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Thase ME. New approaches to managing difficult-to-treat depressions. J Clin Psychiatry. 2003;64:3–4.

    Article  CAS  PubMed  Google Scholar 

  49. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–17.

    Article  PubMed  Google Scholar 

  50. Emslie GJ, Mayes T, Porta G, Vitiello B, Clarke G, Wagner KD, et al. Treatment of resistant depression in adolescents (TORDIA): week 24 outcomes. Am J Psychiatry. 2010;167(7):782–91.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Greden J, Riba M, McInnis M. Treatment resistant depression: a roadmap for effective care. 1st ed. Arlington: American Psychiatric Publishing; 2011. p. 193–212.

    Google Scholar 

  52. Crismon ML, Trivedi M, Pigott TA, Rush AJ, Hirschfeld RMA, Kahn DA, et al. The Texas medication algorithm project: report of the Texas consensus conference panel on medication treatment of major depressive disorder. J Clin Psychiatry. 1999;60(3):142–56.

    Article  CAS  PubMed  Google Scholar 

  53. Association AP. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157:1.

    Article  Google Scholar 

  54. Jenkins E, Goldner EM. Approaches to understanding and addressing treatment-resistant depression: a scoping review. Depress Res Treat. 2012;2012:469680.

    PubMed  PubMed Central  Google Scholar 

  55. Kaplan MJ, Klinetor NA. Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression. J Nerv Ment Dis. 2000;188(9):596–601.

    Article  CAS  PubMed  Google Scholar 

  56. Flynn H, Himle J. Psychotherapy strategies for treatment resistant depression. In: Greden J, Riba M, McInnis M, editors. Treatment resistant depression: a roadmap for effective care. Arlington: American Psychiatric Publishing; 2011. p. 193–212.

    Google Scholar 

  57. Bryant RA, Gallagher HC, Gibbs L, Pattison P, MacDougall C, Harms L, et al. Mental health and social networks after disaster. Am J Psychiatry. 2017;174(3):277–85.

    Article  PubMed  Google Scholar 

  58. Caspi A. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301(5631):386–959.

    Article  CAS  PubMed  Google Scholar 

  59. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry. 2010;167(5):509–27.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Town JM, Abbass A, Stride C, Bernier D. A randomised controlled trial of intensive short-term dynamic psychotherapy for treatment resistant depression: the Halifax Depression Study. J Affect Disord. 2017;214:15–25.

    Article  PubMed  Google Scholar 

  61. Driessen E, Van HL, Don FJ, Peen J, Kool S, Westra D, et al. The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial. Am J Psychiatry. 2013;170(9):1041–50.

    Article  PubMed  Google Scholar 

  62. Gibbons MB, Gallop R, Thompson D, Luther D, Crits-Christoph K, Jacobs J, et al. Comparative effectiveness of cognitive therapy and dynamic psychotherapy for major depressive disorder in a community mental health setting: a randomized clinical noninferiority trial. JAMA Psychiat. 2016;73(9):904–11.

    Article  Google Scholar 

  63. Wampold BE. How important are the common factors in psychotherapy? An update. World Psychiatry. 2015;14(3):270–7.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry. 2008;165:1408–19.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS, et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry. 2007;164(9):1340–7.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Schoeyen HK, Kessler U, Andreassen OA, Auestad BH, Bergsholm P, Malt UF, et al. Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment. Am J Psychiatry. 2015;172(1):41–51.

    Article  PubMed  Google Scholar 

  67. Parker GB, Graham RK. Clinical characteristics associated with treatment-resistant bipolar disorder. J Nerv Ment Dis. 2017;205(3):188–91.

    Article  PubMed  Google Scholar 

  68. Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, et al. Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2017;174(3):216–29.

    Article  PubMed  Google Scholar 

  69. Search performed 12/24/17, with keywords “treatment,” “resistant,” and “schizophrenia.” https://www.ncbi.nlm.nih.gov/pubmed/.

  70. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia. J Clin Psychiatry. 2002;63(10):892–909.

    Article  PubMed  Google Scholar 

  71. Kane JM. Treatment-resistant schizophrenic patients. J Clin Psychiatry. 1996;57(suppl 9):35–40.

    PubMed  Google Scholar 

  72. U.S. Food and Drug Administration. FDA approves pill with sensor that digitally tracks if patients have ingested their medication [Internet]. 2017 Nov 13 [updated 2017 Nov 14; cited 2017 Dec 7]. Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm584933.htm.

  73. Harrison PJ. Recent genetic findings in schizophrenia and their therapeutic relevance. J Psychopharmacol. 2014;29(2):85–96.

    Article  PubMed  CAS  Google Scholar 

  74. Alanen YCBO. Towards a more humanistic psychiatry: development of need-adapted treatment of schizophrenia group psychoses. Psychosis. 2009;1(2):156–66.

    Article  Google Scholar 

  75. Veling W, Susser E, van Os J, Mackenbach JP, Selten J-P, Hoek HW. Ethnic density of neighborhoods and incidence of psychotic disorders among immigrants. Am J Psychiatry. 2008;165(1):66–73.

    Article  PubMed  Google Scholar 

  76. Varese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, et al. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull. 2012;38(4):661–71.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Selten J-P, Cantor-Graae E. Social defeat: risk factor for schizophrenia? Br J Psychiatry. 2005;187:101–2.

    Article  PubMed  Google Scholar 

  78. Lehman AF, Steinwachs DM. Translating research into practice: the schizophrenia patient outcomes research team (PORT) treatment recommendations. Schizophr Bull. 1998;24(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  79. Altman DG, Bland JM. Absence of evidence is not evidence of absence. Br Med J. 1995;311(7003):485.

    Article  CAS  Google Scholar 

  80. Coursey RD, Keller AB, Farrel EW. Individual psychotherapy and persons with serious mental illness: the clients’ perspective. Schizophr Bull. 1995;21(2):283–301.

    Article  CAS  PubMed  Google Scholar 

  81. Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Qoldberg R, et al. The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2003 Schizophrenia Bulletin. Schizophr Bull. 2004;30(2):193–217.

    Article  PubMed  Google Scholar 

  82. Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010;36(1):48–70.

    Article  PubMed  Google Scholar 

  83. Azrin ST, Goldstein AB, Heinssen RK. Early intervention for psychosis: the recovery after an initial schizophrenia episode project. Psychiatr Ann. 2015;45(11):548–53.

    Article  Google Scholar 

  84. Alanen YO, Lehtinen K, Räkköläinen V, Aaltonen J. Need-adapted treatment of new schizophrenic patients: experiences and results of the Turku project. Acta Psychiatr Scand. 1991;83(5):363–72.

    Article  CAS  PubMed  Google Scholar 

  85. Seikkula J, Alakare B, Aaltonen J. The comprehensive open-dialogue approach in Western Lapland: II. Long-term stability of acute psychosis outcomes in advanced community care. Psychosis. 2011;3(3):192–204.

    Article  Google Scholar 

  86. Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, et al. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry. 2000;57(2):165–72.

    Article  CAS  PubMed  Google Scholar 

  87. Alanen YO. Towards a more humanistic psychiatry: development of need-adapted treatment of schizophrenia group psychoses. Psychosis. 2009;1(2):156–66.

    Article  Google Scholar 

  88. Gromer J. Need-adapted and open-dialogue treatments: empirically supported psychosocial interventions for schizophrenia and other psychotic disorders. Ethical Hum Psychol Psychiatry. 2012;14(3):162–77.

    Article  Google Scholar 

  89. Rosenbaum B, Martindale B, Summers A. Supportive psychodynamic psychotherapy for psychosis. Adv Psychiatr Treat. 2013;19(4):310–8.

    Article  Google Scholar 

  90. Rosenbaum B, Harder S, Knudsen P, Køster A, Lindhardt A, Lajer M, et al. Supportive psychodynamic psychotherapy versus treatment as usual for first-episode psychosis: two-year outcome. Psychiatry: Interpersonal Biol Process. 2012;75(4):331–41.

    Article  Google Scholar 

  91. Martindale B, Summers A. The psychodynamics of psychosis. Adv Psychiatr Treat. 2013;19(2):124–31.

    Article  Google Scholar 

  92. Bystritsky A. Treatment-resistant anxiety disorders. Mol Psychiatry. 2006;11(9):805–14.

    Article  CAS  PubMed  Google Scholar 

  93. Tolpin M. On the beginnings of a cohesive self: an application of the concept of transmuting internalization to the study of the transitional object and signal anxiety. Psychoanal Study Child. 197(26):316–52.

    Article  CAS  PubMed  Google Scholar 

  94. Plakun EM. Psychoanalytic treatment of anxiety disorders, obsessive-compulsive and trauma-related disorders. In: Kaplan & Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Walters Kluwer; 2017. p. 2666–72.

    Google Scholar 

  95. Leichsenring F, Salzer S, Jaeger U, Kachele H, Kreische R, Leweke F, et al. Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial. Am J Psychiatry. 2009;166(8):875–81.

    Article  PubMed  Google Scholar 

  96. Shear MK, Cooper AM, Klerman GL, Busch FN, Shapiro T. A psychodynamic model of panic disorder. Am J Psychiatry. 1993;150:859–66.

    Article  CAS  PubMed  Google Scholar 

  97. Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin JF, et al. A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry. 2007;164(2):265–72.

    Article  PubMed  Google Scholar 

  98. Stein DJ, Louw K-A. Management of treatment-resistant post-traumatic stress disorder. In: Nemeroff CB, editor. Management of treatmentresistant major psychiatric disorders. Oxford, New York: Oxford University Press; 2012.

    Google Scholar 

  99. Management of Post-Traumatic Stress Working Group. Management of posttraumatic stress disorder and acute stress reaction 2017 – VA/DoD Clinical Practice Guidelines. [cited 2017 Dec 18]. Available from: https://www.healthquality.va.gov/guidelines/MH/ptsd/.

  100. Bisson JI, Roberts NP, Andrew M, Cooper R, Lewis C. Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. In: The Cochrane Collaboration, editor. Cochrane database of systematic reviews. Chichester: Wiley; 2013 [cited 2017 Dec 18]. Available from. https://doi.org/10.1002/14651858.CD003388.pub4.

    Chapter  Google Scholar 

  101. Gilboa-Schechtman E, Foa E, Shafran N, et al. Prolonged exposure vs dynamic therapy for adolescent PTSD: a pilot randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2010;49(10):1034–42.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Levi O, Bar-Haim Y, Kreiss Y, Fruchter E. Cognitive-behavioural therapy and psychodynamic psychotherapy in the treatment of combat-related post-traumatic stress disorder: a comparative effectiveness study. Clin Psychol Psychother. 2016;23(4):298–307.

    Article  PubMed  Google Scholar 

  103. Markowitz JC, Petkova E, Neria Y, Van Meter PE, Zhao Y, Hembree E, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015;172(5):430–40.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Halmi KA. Perplexities of treatment resistance in eating disorders. BMC Psychiatry. 2013;13(1):292.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Fassino S, Abbate-Daga G. Resistance to treatment in eating disorders: a critical challenge. BMC Psychiatry. 2013;13(1):282.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Zipfel S, Wild B, Groß G, Friederich H-C, Teufel M, Schellberg D, et al. Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial. Lancet. 2013;383:127–37.

    Article  PubMed  Google Scholar 

  107. McIntosh VVW, Jordan J, Carter F a, Luty SE, McKenzie JM, Bulik CM, et al. Three psychotherapies for anorexia nervosa: a randomized, controlled trial. Am J Psychiatry. 2005;162(4):741–7.

    Article  PubMed  Google Scholar 

  108. Poulsen S, Lunn S, Daniel SIF, Folke S, Mathiesen BB, Katznelson H, et al. A randomized controlled trial of psychoanalytic psychotherapy or cognitive-behavioral therapy for bulimia nervosa. Am J Psychiatry. 2014;171(1):109–16.

    Article  PubMed  Google Scholar 

  109. Stefini A, Salzer S, Reich G, Horn H, Winkelmann K, Bents H, et al. Cognitive-behavioral and psychodynamic therapy in female adolescents with bulimia nervosa: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2017;56(4):329–35.

    Article  PubMed  Google Scholar 

  110. Fairburn CG, Jones R, Peveler RC, Hope RA, O’Connor M. Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy. Arch Gen Psychiatry. 1993;50:419–28.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Austen Rigges Center, Stockbridge, MA, USA

    Elizabeth Weinberg, Erin Seery & Eric M. Plakun

Authors
  1. Elizabeth Weinberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erin Seery
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric M. Plakun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth Weinberg .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, College of Medicine, Korea University, Seoul, Korea (Republic of)

    Yong-Ku Kim

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Weinberg, E., Seery, E., Plakun, E.M. (2019). A Psychodynamic Approach to Treatment Resistance. In: Kim, YK. (eds) Treatment Resistance in Psychiatry. Springer, Singapore. https://doi.org/10.1007/978-981-10-4358-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-4358-1_20

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-4357-4

  • Online ISBN: 978-981-10-4358-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation